Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine

By Chris Wack Imunon shares rose after the company received clearance from the U.S. Food and Drug Administration to begin a Phase 1 clinical trial with a seasonal Covid-19 booster vaccine. Shares we

WSJApr 18 10:23 ET

Express News | IMUNON's IND Application Cleared By FDA To Begin Human Testing Of IMNN-101

Moomoo 24/7Apr 18 08:30 ET

IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101

PDF Version Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarterLAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IM

ImunonApr 18 00:00 ET

Express News | Imunon Reports Compliance With Nasdaq Listing Requirements

Moomoo 24/7Apr 11 08:04 ET

IMUNON Reports Compliance With Nasdaq Listing Requirements

PDF Version LAWRENCEVILLE, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) ("IMUNON" or the "Company"), a clinical-stage drug-development company focused on developing DNA-

ImunonApr 11 00:00 ET

Imunon Withdraws Filing for Securities Offering

Imunon Withdraws Filing for Securities Offering

Dow JonesApr 10 16:11 ET